Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 7/2010

01-07-2010 | Review

Glutathione S-Transferase T1 (GSTT1) Gene Polymorphism and Gastric Cancer Susceptibility: A Meta-Analysis of Epidemiologic Studies

Authors: Bo Chen, Lei Cao, Yong Zhou, Ping Yang, Hong-Wei Wan, Gui-Qing Jia, Liu Liu, Xiao-Ting Wu

Published in: Digestive Diseases and Sciences | Issue 7/2010

Login to get access

Abstract

Purpose

Studies investigating the association between genetic polymorphism of glutathione S-transferase T1 (GSTT1) and gastric cancer risk have reported conflicting results. Therefore, we conducted this meta-analysis to provide more precise evidence.

Methods

We searched the databases Medline, PubMed, Embase, and China National Knowledge Infrastructure up to July 30, 2009. Thirty-six studies with 4,357 gastric cancer cases and 9,796 controls were selected. Odds ratio (OR) and 95% confidence intervals (CI) were calculated based on fixed- and random-effects models.

Results

The combined results based on all studies showed there was a significant link between GSTT1 null genotype and gastric cancer risk (OR = 1.14, 95%CI = 1.01–1.28). In subgroup analysis stratified on the basis of ethnic group, we also observed positive association between GSTT1 polymorphism and gastric cancer risk among Caucasians (non-Europeans + non-Americans), but not among East Asians. When stratifying by control source, the overall ORs for population- and hospital-based studies were 1.09 (95%CI = 0.94–1.28) and 1.17 (95%CI = 1.03–1.34), respectively. Subjects with both GSTM1 and GSTT1 negative genotypes had increased gastric cancer risk compared with those who had nonnull genotypes of both GST genes. Subgroup analyses for Helicobacter pylori infection and smoking habit did not reveal any significant association between GSTT1 polymorphism and gastric cancer development.

Conclusions

This meta-analysis suggests that GSTT1 gene polymorphism may be not associated with increased gastric cancer risk among Europeans, Americans, and East Asians. More large-scale studies based on the same racial group are needed.
Literature
1.
Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.CrossRefPubMed
2.
Brenner H, Rothenbacher D, Arndt V. Epidemiology of stomach cancer. Methods Mol Biol. 2009;472:467–477.CrossRefPubMed
3.
Forman D, Burley VJ. Gastric cancer: Global pattern of the disease and an overview of environmental risk factors. Best Pract Res Clin Gastroenterol. 2006;20:633–649.CrossRefPubMed
4.
Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94:153–156.CrossRefPubMed
5.
Yang L. Incidence and mortality of gastric cancer in China. World J Gastroenterol. 2006;12:17–20.PubMed
6.
Saadat M. Genetic polymorphisms of glutathione S-transferase T1 (GSTT1) and susceptibility to gastric cancer: A meta-analysis. Cancer Sci. 2006;97:505–509.CrossRefPubMed
7.
Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol. 1995;30:445–600.CrossRefPubMed
8.
Aydemir B, Onaran I, Kiziler AR, Alici B, Akyolcu MC. Increased oxidative damage of sperm and seminal plasma in men with idiopathic infertility is higher in patients with glutathione S-transferase Mu-1 null genotype. Asian J Androl. 2007;9:108–115.CrossRefPubMed
9.
Ali-Osman F, Akande O, Antoun G, Mao JX, Buolamwini J. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem. 1997;272:10004–10012.CrossRefPubMed
10.
Garte S, Gaspari L, Alexandrie AK, et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev. 2001;10:1239–1248.PubMed
11.
Zhou Y, Li N, Zhuang W, et al. Glutathione S-transferase P1 gene polymorphism associated with gastric cancer among Caucasians. Eur J Cancer. 2009;45:1438–1442.CrossRefPubMed
12.
Agudo A, Sala N, Pera G, et al. Polymorphisms in metabolic genes related to tobacco smoke and the risk of gastric cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev. 2006;15:2427–2434.CrossRefPubMed
13.
Al-Moundhri MS, Alkindy M, Al-Nabhani M, et al. Combined polymorphism analysis of glutathione S-transferase M1/G1 and interleukin-1B (IL-1B)/interleukin 1-receptor antagonist (IL-1RN) and gastric cancer risk in an Omani Arab population. J Clin Gastroenterol. 2009;43:152–156.CrossRefPubMed
14.
Boccia S, Sayed-Tabatabaei FA, Persiani R. Polymorphisms in metabolic genes, their combination and interaction with tobacco smoke and alcohol consumption and risk of gastric cancer: A case-control study in an Italian population. BMC Cancer. 2007;7:206.CrossRefPubMed
15.
Cai L, Yu SZ, Zhang ZF. Glutathione S-transferases M1, T1 genotypes and the risk of gastric cancer: A case-control study. World J Gastroenterol. 2001;7:506–509.PubMed
16.
Choi SC, Yun KJ, Kim TH, et al. Prognostic potential of glutathione S-transferase M1 and T1 null genotypes for gastric cancer progression. Cancer Lett. 2003;195:169–175.PubMed
17.
Colombo J, Rossit AR, Caetano A, Borim AA, Wornrath D, Silva AE. GSTT1, GSTM1 and CYP2E1 genetic polymorphisms in gastric cancer and chronic gastritis in a Brazilian population. World J Gastroenterol. 2004;10:1240–1245.PubMed
18.
Deakin M, Elder J, Hendrickse C, et al. Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: Studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis. 1996;17:881–884.CrossRefPubMed
19.
Gao CM, Takezaki T, Wu JZ, et al. Glutathione-S-transferases M1 (GSTM1) and GSTT1 genotype, smoking, consumption of alcohol and tea and risk of esophageal and stomach cancers: A case-control study of a high-incidence area in Jiangsu Province, China. Cancer Lett. 2002;188:95–102.CrossRefPubMed
20.
Hong SH, Kim JW, Kim HG, et al. Glutathione S-transferases (GSTM1, GSTT1 and GSTP1) and N-acetyltransferase 2 polymorphisms and the risk of gastric cancer. J Prev Med Public Health. 2006;39:135–140.PubMed
21.
Katoh T, Nagata N, Kuroda Y, et al. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis. 1996;17:1855–1859.CrossRefPubMed
22.
Lan Q, Chow WH, Lissowska J, et al. Glutathione S-transferase genotypes and stomach cancer in a population-based case-control study in Warsaw, Poland. Pharmacogenetics. 2001;11:655–661.CrossRefPubMed
23.
Martínez C, Martín F, Fernández JM, et al. Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans. Pharmacogenomics. 2006;7:711–718.CrossRefPubMed
24.
Masoudi M, Saadat I, Omidvari S, Saadat M. Genetic polymorphisms of GSTO2, GSTM1, and GSTT1 and risk of gastric cancer. Mol Biol Rep. 2009;36:781–784.CrossRefPubMed
25.
Moy KA, Yuan JM, Chung FL, et al. Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms and gastric cancer risk: A prospective study of men in Shanghai, China. Int J Cancer. 2009. doi 10.​1002/​ijc.​24583.
26.
Mu LN, Lu QY, Yu SZ, et al. Green tea drinking and multigenetic index on the risk of stomach cancer in a Chinese population. Int J Cancer. 2005;116:972–983.CrossRefPubMed
27.
Nan HM, Park JW, Song YJ, et al. Kimchi and soybean pastes are risk factors of gastric cancer. World J Gastroenterol. 2005;11:3175–3181.PubMed
28.
Palli D, Saieva C, Gemma S, et al. GSTT1 and GSTM1 gene polymorphisms and gastric cancer in a high-risk Italian population. Int J Cancer. 2005;115:284–289.CrossRefPubMed
29.
Qian Y, Xu YC, Shen HB, et al. A molecular epidemiological study on the relationship between glutathione S-transferase M1, T1 genetic polymorphism and susceptibility to gastric cancer (in Chinese). Zhong Guo Gong Gong Wei Sheng. 2001;17:101–103.
30.
Roth MJ, Abnet CC, Johnson LL, et al. Polymorphic variation of Cyp1A1 is associated with the risk of gastric cardia cancer: A prospective case-cohort study of cytochrome P-450 1A1 and GST enzymes. Cancer Causes Control. 2004;15:1077–1083.CrossRefPubMed
31.
Ruzzo A, Canestrari E, Maltese P, et al. Polymorphisms in genes involved in DNA repair and metabolism of xenobiotics in individual susceptibility to sporadic diffuse gastric cancer. Clin Chem Lab Med. 2007;45:822–828.CrossRefPubMed
32.
Saadat I, Saadat M. Glutathione S-transferase M1 and T1 null genotypes and the risk of gastric and colorectal cancers. Cancer Lett. 2001;169:21–26.CrossRefPubMed
33.
Setiawan VW, Zhang ZF, Yu GP, et al. GSTT1 and GSTM1 null genotypes and the risk of gastric cancer: A case-control study in a Chinese population. Cancer Epidemiol Biomarkers Prev. 2000;9:73–80.PubMed
34.
Sgambato A, Campisi B, Zupa A, et al. Glutathione S-transferase (GST) polymorphisms as risk factors for cancer in a highly homogeneous population from southern Italy. Anticancer Res. 2002;22:3647–3652.PubMed
35.
Shen J, Wang RT, Xing HX, et al. Case-control study of the polymorphisms of phase I and phase II metabolic genes and stomach cancer susceptibility (in Chinese). Zhong Liu Za Zhi. 2002;22:9–13.
36.
Shen XB, Zhang J, Zhu LJ, Pu YP. Relationship between glutathione S-transferase M1, T1 genetic polymorphisms, smoking and alcohol consumption and susceptibility to stomach cancer (in Chinese). Huan Jing Yu Jian Kang Za Zhi. 2004;21:210–214.
37.
Tamer L, Ateş NA, Ateş C, et al. Glutathione S-transferase M1, T1 and P1 genetic polymorphisms, cigarette smoking and gastric cancer risk. Cell Biochem Funct. 2005;23:267–272.CrossRefPubMed
38.
Torres MM, Acosta CP, Sicard DM, Groot de Restrepo H. Genetic susceptibility and risk of gastric cancer in a human population of Cauca, Colombia. Biomedica. 2004;24:153–162.PubMed
39.
Tripathi S, Ghoshal U, Ghoshal UC, et al. Gastric carcinogenesis: Possible role of polymorphisms of GSTM1, GSTT1, and GSTP1 genes. Scand J Gastroenterol. 2008;43:431–439.CrossRefPubMed
40.
Wang KY, Lin JT, Chen CJ, Hsieh LL. The relationship between the genotypes of cancer susceptibility genes and the development of gastric cancer (in Chinese). Zhong Hua Gong Gong Wei Sheng Za Zhi. 1998;17:226–241.
41.
Wideroff L, Vaughan TL, Farin FM, et al. GST, NAT1, CYP1A1 polymorphisms and risk of esophageal and gastric adenocarcinomas. Cancer Detect Prev. 2007;31:233–236.CrossRefPubMed
42.
Wu MS, Chen CJ, Lin MT, et al. Genetic polymorphisms of cytochrome p450 2E1, glutathione S-transferase M1 and T1, and susceptibility to gastric carcinoma in Taiwan. Int J Colorectal Dis. 2002;17:338–343.CrossRefPubMed
43.
Ye M, Liu JY, Deng CS. Relationship between xenobiotic-metabolizing enzyme gene polymorphisms and genetic susceptibility of gastric cancer (in Chinese). Shi Jie Hua Ren Xiao Hua Za Zhi. 2003;11:1314–1317.
44.
Zendehdel K, Bahmanyar S, McCarthy S, Nyren O, Andersson B, Ye W. Genetic polymorphisms of glutathione S-transferase genes GSTP1, GSTM1, and GSTT1 and risk of esophageal and gastric cardia cancers. Cancer Causes Control. 2009. doi 10.​1007/​s10552-009-9399-7.
45.
Zhang YC, Deng CS, Zhou Y, Zhu YQ. Association of glutathione S-transferase M1 and T1 genetic polymorphisms with Helicobacter pylori infection and gastric adenocarcinoma (in Chinese). Shi Jie Hua Ren Xiao Hua Za Zhi. 2003;11:1306–1309.
46.
Zheng TR, Zheng QH, Gong FS, Xie YQ, Wang XR. Gene deletion polymorphisms of GSTT1 and GSTM1 and susceptibility to stomach neoplasm (in Chinese). Shi Yong Zhong Liu Za Zhi. 2002;17:155–157.
47.
Zhou Q, Zheng ZY, Wang LD, et al. Prevalence of genetic polymorphisms of GSTM1, GSTT1 and GSTP1 in subjects with gastric cardia adenocarcinoma at Linzhou, Henan (in Chinese). Zheng Zhou Da Xue Xue Bao (Yi Xue Ban). 2003;38:327–329.
48.
La Torre G, Boccia S, Ricciardi G. Glutathione S-transferase M1 status and gastric cancer risk: A meta-analysis. Cancer Lett. 2005;217:53–60.CrossRefPubMed
49.
Wang C, Yuan Y, Hunt RH. The association between Helicobacter pylori infection and early gastric cancer: A meta-analysis. Am J Gastroenterol. 2007;102:1789–1798.CrossRefPubMed
50.
Lu WL, Pan KF, Zhang L, Lin DX, Miao XP, You WC. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor alpha and risk of gastric cancer in a Chinese population. Carcinogenesis. 2005;26:631–636.CrossRefPubMed
51.
Zhang J, Dou C, Song Y, et al. Polymorphisms of tumor necrosis factor-alpha are associated with increased susceptibility to gastric cancer: A meta-analysis. J Hum Genet. 2008;53:479–489.CrossRefPubMed
52.
53.
Boccia S, La Torre G, Gianfagna F, Mannocci A, Ricciardi G. Glutathione S-transferase T1 status and gastric cancer risk: A meta-analysis of the literature. Mutagenesis. 2006;21:115–123.CrossRefPubMed
54.
Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet. 2001;29:306–309.CrossRefPubMed
55.
Munafò M. Replication validity of genetic association studies of smoking behavior: What can meta-analytic techniques offer? Nicotine Tob Res. 2004;6:381–382.CrossRefPubMed
56.
Ye Z, Song H. Glutathione s-transferase polymorphisms (GSTM1, GSTP1 and GSTT1) and the risk of acute leukaemia: A systematic review and meta-analysis. Eur J Cancer. 2005;41:980–989.CrossRefPubMed
57.
Garte S. The role of ethnicity in cancer susceptibility gene polymorphisms: The example of CYP1A1. Carcinogenesis. 1998;19:1329–1332.CrossRefPubMed
58.
Yamaoka Y, Kato M, Asaka M. Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains. Intern Med. 2008;47:1077–1083.CrossRefPubMed
59.
Benhamou S, Lee WJ, Alexandrie AK, et al. Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis. 2002;23:1343–1350.CrossRefPubMed
60.
Raimondi S, Botteri E, Iodice S, Lowenfels AB, Maisonneuve P. Gene–smoking interaction on colorectal adenoma and cancer risk: Review and meta-analysis. Mutat Res Fundam Mol Mech Mutagen. 2009. doi 10.​1016/​j.​mrfmmm.​2009.​06.​013.
61.
Ruzzo A, Graziano F, Pizzagalli F, et al. Interleukin 1B gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in Helicobacter pylori-negative gastric cancer of intestinal and diffuse histotype. Ann Oncol. 2005;16:887–892.CrossRefPubMed
62.
El-Omar EM. Role of host genes in sporadic gastric cancer. Best Pract Res Clin Gastroenterol. 2006;20:675–686.CrossRefPubMed
63.
Li C, Xia HH, Xie W, et al. Association between interleukin-1 gene polymorphisms and Helicobacter pylori infection in gastric carcinogenesis in a Chinese population. J Gastroenterol Hepatol. 2007;22:234–239.CrossRefPubMed
64.
65.
Pavanello S, Clonfero E. Biological indicators of genotoxic risk and metabolic polymorphisms. Mutat Res. 2000;463:285–308.CrossRefPubMed
66.
Strange RC, Spiteri MA, Ramachandran S, et al. Glutathione S-transferase family of enzymes. Mutat Res. 2001;482:21–26.PubMed
67.
Wu MS, Shun CT, Huang SP, Cheng AL, Chen LT, Lin JT. Effect of interleukin-1beta and glutathione S-transferase genotypes on the development of gastric mucosa-associated lymphoid tissue lymphoma. Haematologica. 2004;89:1015–1017.PubMed
Metadata
Title
Glutathione S-Transferase T1 (GSTT1) Gene Polymorphism and Gastric Cancer Susceptibility: A Meta-Analysis of Epidemiologic Studies
Authors
Bo Chen
Lei Cao
Yong Zhou
Ping Yang
Hong-Wei Wan
Gui-Qing Jia
Liu Liu
Xiao-Ting Wu
Publication date
01-07-2010
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 7/2010
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-009-1000-4

Other articles of this Issue 7/2010

Digestive Diseases and Sciences 7/2010 Go to the issue

Original Article

Prevalence of Barrett’s Esophagus Remains Low in the Korean Population: Nationwide Cross-Sectional Prospective Multicenter Study

Original Article

Digital Quantification Is More Precise than Traditional Semiquantitation of Hepatic Steatosis: Correlation with Fibrosis in 220 Treatment-Naïve Patients with Chronic Hepatitis C

Original Article

Trends in Gastroesophageal Reflux Disease as Measured by the National Ambulatory Medical Care Survey

Original Article

Socioeconomic and Other Predictors of Colonoscopy Preparation Quality

Original Article

JC Virus T-Antigen DNA in Gastrointestinal Mucosa of Immunosuppressed Patients: A Prospective, Controlled Study

Original Article

Effect of Helicobacter bilis Infection on Human Bile Duct Cancer Cells
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits